Regulation and function of cdk5 and ezrin in senescence
cdk5和ezrin在衰老过程中的调控和功能
基本信息
- 批准号:7105738
- 负责人:
- 金额:$ 25.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-07 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:actin binding proteinactinsathymic mousecell linecell morphologycell proliferationcell senescencecytogeneticscytoskeletal proteinsgene induction /repressiongenetic promoter elementmessenger RNAmolecular dynamicsneoplasm /cancer geneticsneoplastic cellneoplastic transformationprotein protein interactiontransfectiontumor suppressor proteins
项目摘要
DESCRIPTION (provided by applicant): Cellular senescence is a tumor-suppressive process characterized by an irreversible cell cycle exit, a unique morphology, and expression of senescence-associated-beta-galactosidase (SA-beta-gal). Passage of normal cells in culture leads to senescence, as do cellular stresses including ras oncoprotein expression and activation of the pRb tumor suppressor pathway. Despite the potential biological importance of cellular senescence, little is known of the mechanisms leading to the senescent phenotype in cultured cells, nor is it clear to what extent these processes occur in vivo. We have recently discovered a role for cdk5 in induction of SA-beta-gal expression and senescent cytoskeletal changes. Cdk5 activity increases in senescing cells and repression of the activity of the GTPase Rac1 by cdk5 is required for expression of SA-beta-gal. Cdk5 regulation of Pad activity is also necessary for actin polymerization accompanying senescent morphology in response to expression of pRb, activated ras, or continuous passage. Inhibition of cdk5 attenuates SA-beta-gal expression and blocks actin polymerization. We have further discovered that one substrate for cdk5 in senescent cells is the ERM protein ezrin. Expression of active pRb induces expression and altered localization of ezrin, an actin-binding protein involved in membrane-cytoskeletal signaling. pRb expression results in the stimulation of cdk5-mediated phosphorylation of ezrin with subsequent membrane association and induction of cell shape changes, linking pRb activity to cytoskeletal regulation in senescent cells. These results begin to illuminate the mechanisms underlying induction of senescence and the senescent shape change and describe new pathways that may contribute to the ability of senescent cells to influence tumor growth. In order to more clearly understand the role of cdk5 and ERMs in senescence and tumor suppression, three specific aims are proposed: 1) Determine the mechanism of activation of cdk5 in senescent cells. 2) Determine how pRb activates transcription of the ezrin gene and use this information to understand transcriptional responses to pRb in senescent cells. 3) Ascertain the effects of constitutive cdk5 or ERM "knock-down" or loss on proliferation and tumorigenesis.
描述(由申请人提供):细胞衰老是一种肿瘤抑制过程,其特征为不可逆的细胞周期退出、独特的形态和衰老相关β-半乳糖苷酶(SA-β-gal)的表达。正常细胞在培养物中的传代导致衰老,细胞应激包括ras癌蛋白表达和pRb肿瘤抑制途径的激活也是如此。尽管细胞衰老具有潜在的生物学重要性,但对培养细胞中导致衰老表型的机制知之甚少,也不清楚这些过程在体内发生的程度。我们最近发现cdk 5在诱导SA-β-gal表达和衰老细胞骨架变化中的作用。Cdk 5活性在衰老细胞中增加,并且SA-β-gal的表达需要Cdk 5抑制GTdR ac 1的活性。Cdk 5调节垫活性也是必要的肌动蛋白聚合伴随衰老的形态响应表达的pRb,激活ras,或连续通过。cdk 5的抑制减弱SA-β-gal表达并阻断肌动蛋白聚合。我们进一步发现,衰老细胞中cdk 5的一种底物是ERM蛋白ezrin。活性pRb的表达诱导ezrin的表达和改变定位,ezrin是一种参与膜细胞骨架信号传导的肌动蛋白结合蛋白。pRb表达导致cdk 5介导的ezrin磷酸化的刺激,随后的膜缔合和诱导细胞形状变化,将pRb活性与衰老细胞中的细胞骨架调节联系起来。这些结果开始阐明了诱导衰老和衰老形状变化的潜在机制,并描述了可能有助于衰老细胞影响肿瘤生长的能力的新途径。为了更清楚地了解cdk 5和ERMs在衰老和肿瘤抑制中的作用,提出了三个具体目标:1)确定衰老细胞中cdk 5的激活机制。2)确定pRb如何激活ezrin基因的转录,并利用这些信息来了解衰老细胞中pRb的转录反应。3)确定组成性cdk 5或ERM“敲低”或缺失对增殖和肿瘤发生的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip W. Hinds其他文献
AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis
AKT2 缺失会损害 BRAF 突变黑色素瘤转移
- DOI:
10.1101/2023.08.24.554685 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Siobhan K. McRee;Abraham L. Bayer;Jodie Pietruska;Philip N. Tsichlis;Philip W. Hinds - 通讯作者:
Philip W. Hinds
Too Much of a Good Thing: The <em>Prl-3</em> in p53's Oyster
- DOI:
10.1016/j.molcel.2008.04.006 - 发表时间:
2008-05-09 - 期刊:
- 影响因子:
- 作者:
Philip W. Hinds - 通讯作者:
Philip W. Hinds
Philip W. Hinds的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip W. Hinds', 18)}}的其他基金
Regulation and function of cdk5 and ezrin in senescence
cdk5和ezrin在衰老过程中的调控和功能
- 批准号:
7680551 - 财政年份:2006
- 资助金额:
$ 25.75万 - 项目类别:
Regulation and function of cdk5 and ezrin in senescence
cdk5和ezrin在衰老过程中的调控和功能
- 批准号:
7460620 - 财政年份:2006
- 资助金额:
$ 25.75万 - 项目类别:
Regulation and function of cdk5 and ezrin in senescence
cdk5和ezrin在衰老过程中的调控和功能
- 批准号:
7905946 - 财政年份:2006
- 资助金额:
$ 25.75万 - 项目类别:
Regulation and function of cdk5 and ezrin in senescence
cdk5和ezrin在衰老过程中的调控和功能
- 批准号:
7893947 - 财政年份:2006
- 资助金额:
$ 25.75万 - 项目类别:
相似海外基金
A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
- 批准号:
22KJ2613 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Grant-in-Aid for JSPS Fellows
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
- 批准号:
10552100 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
- 批准号:
10520211 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Thick and Thin Filament Dysfunction in Obese Heart Failure with Preserved Ejection Fraction
射血分数保留的肥胖性心力衰竭的粗细丝功能障碍
- 批准号:
10678204 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
- 批准号:
10677169 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Cytoskeleton-mediated regulation of insulin secretion hot spots in pancreatic beta cells
细胞骨架介导的胰腺β细胞胰岛素分泌热点的调节
- 批准号:
10679903 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Decoding dynamic interplay between signaling and membranes in chemotaxis bymolecular actuators
通过分子致动器解码趋化中信号传导和膜之间的动态相互作用
- 批准号:
10846921 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Modulators of cardiomyocyte structure to promote functional recovery during cardiac regeneration and repair
心肌细胞结构调节剂促进心脏再生和修复过程中的功能恢复
- 批准号:
10751640 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies
用他汀类药物靶向转录共激活剂 YAP 和 TAZ,以防止 HLA 供体特异性抗体导致实体器官移植排斥
- 批准号:
10734277 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别: